Japan approves Biomerica's 10-minute PSA (prostate specific antigen) test:
This article was originally published in Clinica
The Japanese Ministry of Health has approved for sale Biomerica's 10-minute, disposable prostate specific antigen (PSA) test for prostate cancer screening. The EZ-PSA is an easy-to-use, one-step, finger-prick-based blood test for use in a doctor's office. It indicates whether a patient has an elevated level of PSA, which can provide an early marker for the disease. "We are very optimistic about this market because the incidence of prostate cancer in Japan has been on the rise over the past 10 years" says Francis Capitanio, president of the Newport Beach, California, company.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.